Think beyond engineering and medicine.
'This health emergency has brought a lot of people together with the common purpose of getting Feluda to play detective as quickly as possible.' 'As a scientist, if we can make a small difference in people's lives, we are happy'
'Pay-for-delay' settlements between drug patent-holders and generics manufacturers to delay the launch of cheaper generic medicine are increasingly being scrutinised by antitrust regulators
President Pranab Mukherjee's visit to Israel is a final and critical step in the normalisation of relations between the two countries.
Above normal monsoon forecast and strength in Asian equities lifted sentiments.
'India easily remains one among the more attractive large economies, with high growth and stable/improving macros, as a top investment destination.' 'We are looking pretty good.'
Stockmarket Gurus Raamdeo Agrawal, Manish Gunwani, S Naren and Nilesh Shah discuss their favourite themes for the New Year.
Bharat Biotech started work on developing a vaccine against Zika way back in 2014.
But when organisations cushion the impact to make it less traumatic, it helps in the recovery process, Wayne F Cascio tells Abhilasha Ojha
